In a bid to encourage local manufacturing and engender national drug security, the Director General of the Nigerian Association of Foods Drugs Agency and Control (NAFDAC), Prof. Mojisola Adeyeye has reiterated the agency’s commitment by approving a Five year monopoly to Pharmaceutical Manufacturers under the 5+5 Market Exclusivity Policy. Adeyeye revealed this while addressing stakeholders in the pharmaceutical industry at the inauguration of the 5th Nigeria Pharma Manufacturers Expo in Lagos. She stressed that at the completion of 10 years, the companies would be expected to manufacture the drugs in the country.
In addition, Adeyeye expressed concern and great sadness over the rise in infant and maternal mortality in Africa, majority of which is fuelled by unavailability of drugs. She added that the goal of NAFDAC is to strengthen the local manufacturers so as to ensure that the country has drug security.
“We want to make sure we are manufacturing as many as possible drugs we need locally. We can only achieve this if we are customer-focused and agency-minded. Ofcourse we cannot manufacture everything in Nigeria, we want to change the trend from 30-40 percent local to 60-70 percent local.”
She stressed that the African traders’ agreement may be a making point or a breaking point for Nigeria. However, she confidently said that with over 200 local manufacturers, Nigeria is poised to take on the AfCFTA and use it advantageously.
“Until NAFDAC is strong the Pharma industry is not strong, NAFDAC is 10 times stronger and the pharmaceutical industry is 10 times stronger. What we are doing now with PMG-MAN is to have an exclusivity list of drugs we do not want imported into our country. It will be between 40 and 60 because we have to protect the local manufacturers.”